The recall comes in the wake of the UK Food Standards Agency’s warning that CBD should be avoided by certain demographics
Number of cannabidiol (CBD)-infused products in the UK have been made the subject of immediate recall. Excessive levels of tetrahydrocannabinol, the intoxicating compound derived from the cannabis plant, were found in the goods.
The Food Safety Authority of Ireland (FSAI) declared the recall when “unsafe levels of delta‐9‐tetrahydrocannabinol (THC) was detected in batches of CBD foods and food supplements.”
CBD is a psychoactive but non-intoxicating compound derived from the cannabis plant and is often used to treat ailments such as anxiety, insomnia, and inflammation.
The Authority has emphasized that most users aren’t subject to any immediate dangers as a result of consuming the products, but that the intoxicating effects are in excess of what is legally acceptable under the regulations of the European Union.
The recall comes in the wake of the UK Food Standards Agency’s warning that CBD should be avoided by certain demographics such as pregnant and breastfeeding women and those who take other prescription medications, and that less than 70 mg of the cannabinoid should be consumed daily.
The Agency also warned CBD businesses that the products could be removed from retail shelves if the products were not adequately labelled and contents disclosed by March 2021. Producers must apply to the Agency for “novel food authorisation” to ensure the safety of the product, with chief executive Emily Miles pointing out that while CBD products are “widely available on the high street,” many are unauthorised.
“The CBD industry must provide more information about the safety and contents of these products to the regulator before 31 March 2021, or the products will be taken off the shelves,” Miles said in a statement this week.
“Also today, we are advising that CBD could be risky for vulnerable groups, and suggesting an upper limit of 70mg a day for everyone else taking the product.”
The incident is reminiscent of a recent recall of mislabelled gelcaps from Canadian licensed producers Zenabis. The THC caps, which were labelled as containing CBD, were stocked on store shelves in the province of New Brunswick before a recall was issued in mid-December.
Subscribe to the Cannabis Post newsletter.
Written by Emma Spears